| Video
Dr. Argoff comments on the appropriate role of opioid analgesics as part of therapy for chronic noncancer pain, with observations on protecting legitimate access while preventing abuse.
| Video
The conclusion of a 2-part discussion. Some specific limitations of UTD as a clinical tool are examined. Drs. Gourlay and Heit also consider the role of opioids in chronic pain management, with balanced regard for the risks of pain and addiction.
| Video
Part one of a 2-part discussion. The concept of patient-centered UDT as a clinical tool for monitoring adherence is considered. Drs. Gourlay and Heit also offer some guidelines for practitioners on who and when to test.
| Article
The Iceberg Cometh
Dr. Passik is Director, Clinical Addiction Research and Education, Millenium Laboratories Clinical Education, San Diego, California. He has over 25 years’ experience in clinical practice as a pain psychologist specializing in addiction medicine. He is also a longtime member of...
| Video
Observations by a pain management educator and lawyer on some key issues for pain medication prescribers.
| Video
Observations by a pain management educator and lawyer on some key issues for pain medication prescribers.
| Article
It’s important to start at the beginning and screen patients for indicators that could be suggestive of abuse, misuse, diversion, and unintentional use. We can use actual validated instruments to screen for patients who may have some issues with misuse and abuse and diversion. It is an important...
| Video
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities.
| Video
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities.
| Video
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities.